-
Oncology Precision Medicine: Challenges and Opportunities for Biopharmaceutical Companies
25 Apr 2024 10:12 GMT
… researchers during precision medicine trials for cancer treatment. The genetic … medicine relies heavily on complex data such as clinical trial … immunotherapy approaches including ipilimumab and immune checkpoint … from the FDA of an investigational new drug (IND …
-
Validation of the Lung Immune Prognostic Index (LIPI) as a prognostic biomarker in metastatic renal cell carcinoma.
25 Apr 2024 10:06 GMT
… trial: VEGF/VEGFR-targeted therapy (TT); CheckMate 214: nivolumab-ipilimumab vs … in mRCC irrespective of systemic treatment used.
European journal of cancer … ;Azur, Nice, France., Department of Medical Oncology, Bordeaux University Hospital, Bordeaux …
-
Comprehensive Review Highlights Potential Benefits of Leukine® in Management of Gastrointestinal (GI) Adverse Events Associated with Immune Checkpoint Inhibitors (ICIs) in the Treatment of Cancer
19 Apr 2024 11:03 GMT
… Medicine at Massachusetts General Hospital. "Unfortunately, these drugs … Ipilimumab Alone for Treatment of Metastatic Melanoma: A Randomized Clinical Trial … in controlled clinical trials and reported … (PTx), an integrated biotechnology company, focuses on …
-
Ultimovacs downsizes to funnel funds to cancer vaccine programme
17 Apr 2024 17:42 GMT
… ) and Yervoy (ipilimumab) as a second-line treatment in mesothelioma patients … trials. The Phase II FOCUS trial (NCT05075122) evaluates the combination treatment of UV1 vaccine … the treatment of head and neck cancers and ISA Pharmaceuticals’ cancer vaccine, …
-
The Role of Molecular Profiling in Optimizing Treatment Decisions for RCC
17 Apr 2024 12:30 GMT
… to help better guide treatment decisions.
Matthew T. Campbell … linking to a preferred treatment option.
Campbell, an … select nivolumab plus ipilimumab [as a treatment] because response rates … in discussing. Nivolumab and ipilimumab have improved QOL compared …
-
Checkpoint Inhibitors: A New Hope for Cancer Treatment
17 Apr 2024 17:02 GMT
… , to understand how medicines could boost the immune … The Bristol-Myers Squibb Pharmaceutical Research Institute revealed in … the treatment’s safety and efficacy. The FDA approved ipilimumab as … promising results in clinical trials for patients with melanoma …
-
Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A).
15 Apr 2024 11:32 GMT
… ;ipilimumab arms of the CheckMate 067 and 214 trials for … the HCRN GU16-260 trial, which was designed to … ;ipilimumab in non-responders is an active treatment approach in treatment- … Regan
Oncology, Georgetown University Medical Center, Washington, District of …
-
Weighing the Balance: Immunotherapy for Cancer Treatment
12 Apr 2024 16:22 GMT
… FDA announced an investigation into the risk of secondary malignancy following treatment … treatment and using steroids. There was a trial … ipilimumab and nivolumab. In that setting, immunosuppressive medication … the treatment, treating more patients with drugs …
-
Dr Michael Morse Discusses Current HCC Treatment Strategies and Future Directions
05 Apr 2024 23:29 GMT
… of medicine at Duke University School of Medicine and medical oncologist … any ongoing trials or potential new HCC treatment strategies you… there was a pembrolizumab trial that did meet its … there, particularly nivolumab plus ipilimumab—again, not compared with …
-
Personalized Vaccine Yields Early PFS Benefit in Metastatic MSS-CRC
02 Apr 2024 22:08 GMT
… treatment, which investigators described as comparable with prior reports of the vaccine … a professor of Clinical Medicine and director of the … a confirmatory phase 3 trial, about which I am … included atezolizumab (Tecentriq) and ipilimumab (Yervoy).2
As of …